Purinergic P2Y2 receptor–induced activation of endothelial TRPV4 channels mediates lung ischemia-reperfusion injury
Science Signaling · 2023
DOI: 10.1126/scisignal.adg1553 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Signaling, 2023. Verfasst von Maniselvan Kuppusamy und 9 weiteren Autor:innen. Beteiligte Einrichtung: Robert M. Berne Cardiovascular Research Center, University of Virginia, Charlottesville, VA 22908, USA. Hauptthemen laut MEDLINE: TRPV Cation Channels, Reperfusion Injury. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS.
Abstract (Originalsprache)
Lung ischemia-reperfusion injury (IRI), characterized by inflammation, vascular permeability, and lung edema, is the major cause of primary graft dysfunction after lung transplantation. Here, we investigated the cellular mechanisms underlying lung IR–induced activation of endothelial TRPV4 channels, which play a central role in lung edema and dysfunction after IR. In a left lung hilar-ligation model of IRI in mice, we found that lung IRI increased the efflux of ATP through pannexin 1 (Panx1) channels at the endothelial cell (EC) membrane. Elevated extracellular ATP activated Ca 2+ influx through endothelial TRPV4 channels downstream of purinergic P2Y2 receptor (P2Y2R) signaling. P2Y2R-dependent activation of TRPV4 channels was also observed in human and mouse pulmonary microvascular endothelium in ex vivo and in vitro models of IR. Endothelium-specific deletion of P2Y2R, TRPV4, or Panx1 in mice substantially prevented lung IRI–induced activation of endothelial TRPV4 channels and lung edema, inflammation, and dysfunction. These results identify endothelial P2Y2R as a mediator of the pathological sequelae of IRI in the lung and show that disruption of the endothelial Panx1-P2Y2R-TRPV4 signaling pathway could be a promising therapeutic strategy for preventing lung IRI after transplantation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Robert M. Berne Cardiovascular Research Center, University of Virginia, Charlottesville, VA 22908, USA.
- Department of Surgery, University of Virginia, Charlottesville, VA 22908, USA.
- Department of Molecular Physiology and Biological Physics, University of Virginia, Charlottesville, VA 22908, USA.
ORCID-Profile: Maniselvan Kuppusamy, Hannah N Davenport, Yen-Lin Chen, Philip W Carrott, Victor E Laubach, Swapnil K Sonkusare
Förderung
- NHLBI NIH HHS
Zitieren
APA
Kuppusamy, M., Ta, H. Q., Davenport, H. N., Bazaz, A., Kulshrestha, A., Daneva, Z., Chen, Y. L., Carrott, P. W., Laubach, V. E., & Sonkusare, S. K. (2023). Purinergic P2Y2 receptor–induced activation of endothelial TRPV4 channels mediates lung ischemia-reperfusion injury. Science Signaling. https://doi.org/10.1126/scisignal.adg1553
Vancouver
Kuppusamy M, Ta HQ, Davenport HN, Bazaz A, Kulshrestha A, Daneva Z, et al. Purinergic P2Y2 receptor–induced activation of endothelial TRPV4 channels mediates lung ischemia-reperfusion injury. Science Signaling. 2023. doi:10.1126/scisignal.adg1553
BibTeX
@article{Kuppusamy2023,
author = {Kuppusamy, Maniselvan and Ta, Huy Q and Davenport, Hannah N and Bazaz, Abhishek and Kulshrestha, Astha and Daneva, Zdravka and Chen, Yen-Lin and Carrott, Philip W and Laubach, Victor E and Sonkusare, Swapnil K},
title = {Purinergic P2Y2 receptor–induced activation of endothelial TRPV4 channels mediates lung ischemia-reperfusion injury},
journal = {Science Signaling},
year = {2023},
doi = {10.1126/scisignal.adg1553}
}
EUVIMED